Stocks · Sector
Healthcare Stocks - Prices & Analysis (1,175)
| Company | Ticker | Price | Mkt cap | P/E | Div yield |
|---|---|---|---|---|---|
| Greenwich LifeSciences, Inc. | GLSI | $15.95 | $234.12M | — | |
| Protara Therapeutics, Inc. | TARA | $3.94 | $232.84M | — | |
| Innate Pharma S.A. | IPHA | $2.08 | $232.34M | — | |
| Acumen Pharmaceuticals, Inc. | ABOS | $3.18 | $229.97M | — | |
| Sol-Gel Technologies Ltd. | SLGL | $69.52 | $227.61M | — | |
| Utah Medical Products, Inc. | UTMD | $71.10 | $226.37M | 21.7 | 1.75% |
| High Tide Inc. | HITI | $2.57 | $225.39M | — | |
| Tonix Pharmaceuticals Holding Corp. | TNXP | $13.14 | $225.36M | — | |
| Keros Therapeutics, Inc. | KROS | $11.32 | $224.44M | — | |
| Spok Holdings, Inc. | SPOK | $10.71 | $224.03M | 18.8 | 11.67% |
| AN2 Therapeutics, Inc. | ANTX | $5.89 | $222.27M | — | |
| Journey Medical Corporation | DERM | $7.86 | $221.84M | — | |
| American Well Corporation | AMWL | $12.99 | $220.94M | — | |
| Organogenesis Holdings Inc. | ORGO | $1.71 | $220.03M | — | |
| Neuronetics, Inc. | STIM | $2.88 | $219.45M | — | |
| Coherus Oncology, Inc. | CHRS | $1.42 | $219.39M | — | |
| Armata Pharmaceuticals, Inc. | ARMP | $5.84 | $217.14M | — | |
| Voyager Therapeutics, Inc. | VYGR | $3.51 | $216.28M | — | |
| Protalix BioTherapeutics, Inc. | PLX | $2.67 | $215.13M | 11.6 | — |
| PepGen Inc. | PEPG | $3.11 | $215.12M | — | |
| Corbus Pharmaceuticals Holdings, Inc. | CRBP | $11.08 | $214.30M | — | |
| Minerva Neurosciences, Inc. | NERV | $4.43 | $211.52M | — | |
| Nkarta, Inc. | NKTX | $2.92 | $209.14M | — | |
| Oramed Pharmaceuticals Inc. | ORMP | $5.01 | $208.40M | 1.2 | 4.99% |
| NovaBridge Biosciences | NBP | $1.80 | $208.17M | — | |
| Alpha Cognition Inc. Common Stock | ACOG | $9.52 | $207.33M | — | |
| Precision BioSciences, Inc. | DTIL | $7.47 | $206.18M | — | |
| CareRx Corporation | CRRX.TO | CA$3.23 | CA$204.93M | 7.7 | 2.69% |
| AirSculpt Technologies, Inc. | AIRS | $2.80 | $201.51M | — | |
| Cue Biopharma, Inc. Common Stock | CUE | $27.44 | $199.34M | — | |
| Cannara Biotech Inc. | LOVE.TO | CA$1.99 | CA$196.58M | 18.1 | — |
| Custom Health Holdings Inc. | CHLT.TO | CA$7.50 | CA$193.87M | — | |
| EDAP TMS S.A. | FOCL | $4.15 | $190.70M | — | |
| LENZ Therapeutics, Inc. | LENZ | $5.96 | $187.27M | — | |
| Exagen Inc. | XGN | $7.58 | $183.63M | — | |
| Jyong Biotech Ltd. | MENS | $2.39 | $181.71M | — | |
| Canton Strategic Holdings, Inc. | CNTN | $2.28 | $181.67M | — | |
| Korro Bio, Inc. | KRRO | $12.24 | $180.24M | — | |
| WW International, Inc. | WW | $18.02 | $180.18M | 1.6 | — |
| Lucid Diagnostics Inc. | LUCD | $0.94 | $179.40M | — | |
| Immunic, Inc. | IMUX | $13.11 | $178.88M | — | |
| ADC Therapeutics SA | ADCT | $1.36 | $173.63M | — | |
| MediWound Ltd. | MDWD | $13.29 | $171.58M | — | |
| Caribou Biosciences, Inc. | CRBU | $1.57 | $168.32M | — | |
| Humacyte, Inc. | HUMA | $0.61 | $168.04M | — | |
| Quantum-Si incorporated | QSI | $0.77 | $167.67M | — | |
| Molecular Partners AG | MOLN | $4.35 | $166.63M | — | |
| Lifecore Biomedical, Inc. | LFCR | $4.40 | $166.55M | — | |
| Organigram Global Inc. | OGI | $1.16 | $166.50M | 2.7 | — |
| Spruce Biosciences, Inc. | SPRB | $57.93 | $166.49M | — |
Greenwich LifeSciences, Inc.
Healthcare / Biotechnology
- Market Cap
- $234.12M
- P/E
- unprofitable
Protara Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $232.84M
- P/E
- unprofitable
Innate Pharma S.A.
Healthcare / Biotechnology
- Market Cap
- $232.34M
- P/E
- unprofitable
Acumen Pharmaceuticals, Inc.
Healthcare / Biotechnology
- Market Cap
- $229.97M
- P/E
- unprofitable
Sol-Gel Technologies Ltd.
Healthcare / Biotechnology
- Market Cap
- $227.61M
- P/E
- unprofitable
Utah Medical Products, Inc.
Healthcare / Medical Instruments & Supplies
- Market Cap
- $226.37M
- P/E
- 21.7
- Dividend Yield
- 1.75%
High Tide Inc.
Healthcare / Pharmaceutical Retailers
- Market Cap
- $225.39M
- P/E
- unprofitable
Tonix Pharmaceuticals Holding Corp.
Healthcare / Biotechnology
- Market Cap
- $225.36M
- P/E
- unprofitable
Keros Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $224.44M
- P/E
- unprofitable
Spok Holdings, Inc.
Healthcare / Health Information Services
- Market Cap
- $224.03M
- P/E
- 18.8
- Dividend Yield
- 11.67%
AN2 Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $222.27M
- P/E
- unprofitable
Journey Medical Corporation
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $221.84M
- P/E
- unprofitable
American Well Corporation
Healthcare / Health Information Services
- Market Cap
- $220.94M
- P/E
- unprofitable
Organogenesis Holdings Inc.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $220.03M
- P/E
- unprofitable
Neuronetics, Inc.
Healthcare / Medical Devices
- Market Cap
- $219.45M
- P/E
- unprofitable
Coherus Oncology, Inc.
Healthcare / Biotechnology
- Market Cap
- $219.39M
- P/E
- unprofitable
Armata Pharmaceuticals, Inc.
Healthcare / Biotechnology
- Market Cap
- $217.14M
- P/E
- unprofitable
Voyager Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $216.28M
- P/E
- unprofitable
Protalix BioTherapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $215.13M
- P/E
- 11.6
PepGen Inc.
Healthcare / Biotechnology
- Market Cap
- $215.12M
- P/E
- unprofitable
Corbus Pharmaceuticals Holdings, Inc.
Healthcare / Biotechnology
- Market Cap
- $214.30M
- P/E
- unprofitable
Minerva Neurosciences, Inc.
Healthcare / Biotechnology
- Market Cap
- $211.52M
- P/E
- unprofitable
Nkarta, Inc.
Healthcare / Biotechnology
- Market Cap
- $209.14M
- P/E
- unprofitable
Oramed Pharmaceuticals Inc.
Healthcare / Biotechnology
- Market Cap
- $208.40M
- P/E
- 1.2
- Dividend Yield
- 4.99%
NovaBridge Biosciences
Healthcare / Biotechnology
- Market Cap
- $208.17M
- P/E
- unprofitable
Alpha Cognition Inc. Common Stock
Healthcare / Biotechnology
- Market Cap
- $207.33M
- P/E
- unprofitable
Precision BioSciences, Inc.
Healthcare / Biotechnology
- Market Cap
- $206.18M
- P/E
- unprofitable
CareRx Corporation
Healthcare / Medical Care Facilities
- Market Cap
- CA$204.93M
- P/E
- 7.7
- Dividend Yield
- 2.69%
AirSculpt Technologies, Inc.
Healthcare / Medical Care Facilities
- Market Cap
- $201.51M
- P/E
- unprofitable
Cue Biopharma, Inc. Common Stock
Healthcare / Biotechnology
- Market Cap
- $199.34M
- P/E
- unprofitable
Cannara Biotech Inc.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- CA$196.58M
- P/E
- 18.1
Custom Health Holdings Inc.
Healthcare / Health Information Services
- Market Cap
- CA$193.87M
- P/E
- unprofitable
EDAP TMS S.A.
Healthcare / Medical Distribution
- Market Cap
- $190.70M
- P/E
- unprofitable
LENZ Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $187.27M
- P/E
- unprofitable
Exagen Inc.
Healthcare / Diagnostics & Research
- Market Cap
- $183.63M
- P/E
- unprofitable
Jyong Biotech Ltd.
Healthcare / Biotechnology
- Market Cap
- $181.71M
- P/E
- unprofitable
Canton Strategic Holdings, Inc.
Healthcare / Biotechnology
- Market Cap
- $181.67M
- P/E
- unprofitable
Korro Bio, Inc.
Healthcare / Biotechnology
- Market Cap
- $180.24M
- P/E
- unprofitable
WW International, Inc.
Healthcare / Medical Care Facilities
- Market Cap
- $180.18M
- P/E
- 1.6
Lucid Diagnostics Inc.
Healthcare / Medical Devices
- Market Cap
- $179.40M
- P/E
- unprofitable
Immunic, Inc.
Healthcare / Biotechnology
- Market Cap
- $178.88M
- P/E
- unprofitable
ADC Therapeutics SA
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $173.63M
- P/E
- unprofitable
MediWound Ltd.
Healthcare / Biotechnology
- Market Cap
- $171.58M
- P/E
- unprofitable
Caribou Biosciences, Inc.
Healthcare / Biotechnology
- Market Cap
- $168.32M
- P/E
- unprofitable
Humacyte, Inc.
Healthcare / Biotechnology
- Market Cap
- $168.04M
- P/E
- unprofitable
Quantum-Si incorporated
Healthcare / Medical Devices
- Market Cap
- $167.67M
- P/E
- unprofitable
Molecular Partners AG
Healthcare / Biotechnology
- Market Cap
- $166.63M
- P/E
- unprofitable
Lifecore Biomedical, Inc.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $166.55M
- P/E
- unprofitable
Organigram Global Inc.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $166.50M
- P/E
- 2.7
Spruce Biosciences, Inc.
Healthcare / Biotechnology
- Market Cap
- $166.49M
- P/E
- unprofitable
Showing 651–700 of 1,175 · ranked by market capitalization
Where the trailing year was a loss, P/E appears as “unprofitable”; a dash is missing data.